ADVA
ADVA (FSE: ADV) today announced that Partner Communications has deployed its Oscilloquartz timing technology to support 5G rollout throughout Israel. The solution provides the level of accuracy and availability needed for next-generation mobile services and time-sensitive low-latency applications. Featuring ADVA’s Oscilloquartz core grandmaster devices, enhanced primary reference time clock (ePRTC) technology and multi-band GNSS receivers, the new timing infrastructure is ultra-resilient and prepared to withstand the rising threat of jamming and spoofing attacks. ADVA’s partner RDT Equipment & Systems also played a significant role in the deployment, carrying out installation, configuration and troubleshooting. Together with ADVA, it will provide Partner Communication with ongoing maintenance and support.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220607006044/en/
“Upgrading a major nationwide mobile network like ours required the most advanced timing technology and the support of an expert team. That’s why we selected ADVA’s Oscilloquartz synchronization solution built on a core PTP grandmaster clock with full hardware redundancy and a scalable modular design. It offers many fan-out options, including PTP over multiple 10Gbit/s interfaces, and its advanced GNSS technologies ensure highest availability even under challenging conditions,” said Yigal Giladi, VP of engineering at Partner Communications. “With our new timing infrastructure, we can deliver the best possible mobile 5G experience to our customers. Now when GNSS is compromised or otherwise unavailable, ADVA’s ePRTC solution means we can still deliver phenomenally accurate timing across our network even during very long GNSS outages.”
Partner Communications’ new timing infrastructure features the OSA 5440 , a fully redundant, scalable, and modular multi-technology grandmaster for core deployment. Operating with the OSA 3230B ePRC cesium clock and OSA clock combiner, it provides an ePRTC system, providing high levels of time stability compliant with the ITU-T G.8272.1 standard. Onboard multi-band, multi-constellation receivers compensate for atmospheric disturbances to filter out timing errors. What’s more, centralized AI-powered GNSS assurance software identifies and protects against vulnerabilities of satellite-based timing. The solution also includes the OSA 5410 Series for continuous probing and assurance, enabling Partner Communications’ team to anticipate any issues and minimize disruption to service. The technology is remotely controlled by ADVA’s Ensemble Controller with Sync Director. This provides a powerful management platform, giving Partner Communications full visibility of its synchronization infrastructure and assuring accurate timing.
“Partner Communications has taken a major leap forward in terms of the accuracy and reliability of its synchronization network. Their team was determined to make their timing infrastructure the most precise and robust it could be, and so our engineers have worked tirelessly on design, testing and installation to ensure an end-to-end solution that delivers for Partner Communications’ customers now and for many years to come,” commented Hartmut Müller-Leitloff, SVP of sales, EMEA at ADVA. “This timing solution delivers a unique set of features to mitigate GNSS vulnerabilities, such as multi-band, multi-constellation receivers and AI-powered analytics. In a world of increasing jamming and spoofing attacks, this will prove invaluable for mobile users across Israel.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com
.
About Oscilloquartz
Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to-end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA company, we’re creating new opportunities for tomorrow’s networks. For more information, please visit us at www.oscilloquartz.com
.
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220607006044/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press release
The disruption generated by AI enables the acceleration and industrialisation of the creation of internal solutions and start-ups through centres of excellence in Chicago, Madrid and Tbilisi.This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the depl
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press release
Deseyne® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifoc
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press release
Five-year contract to drive innovation in stimulation, intervention, digital and frac automationAgreement underscores gas as a pivotal fuel for global energy demand and a bridge to lower-carbon systems Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconve
Tabelog, Japan's Largest (*1)Restaurant Search and Reservation Service,Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press release
Experience Japan's Authentic Culinary Scene in Your Language — From Search to Reservation, All on Your SmartphoneRanked No. 1 in Downloads Among "Japanese Gourmet Search Apps" Chosen by International Travelers (*2) Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photo
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
